Justin L. Grobe, Ph.D. began his research career in physiological genomics as an undergraduate, working in the laboratory of Christopher C. Barney, Ph.D. at Hope College (in Holland, Michigan), while pursuing degrees in both Biology and Chemistry. Dr. Grobe next completed his graduate work under the tutelage of Michael J. Katovich, Ph.D. and collaborators Mohan K. Raizada, Ph.D. and Colin K. Sumners, Ph.D. at the University of Florida (in Gainesville, Florida). His dissertation work, supported by the American Heart Association’s Florida/Puerto Rico Affiliate and published in six peer-reviewed manuscripts, eight meeting abstracts and a book chapter, focused on the roles of the recently recognized angiotensin-converting enzyme 2 and its principle enzymatic product, angiotensin-(1-7), in protecting the structure and function of the heart during hypertension and following myocardial infarction.

Since receiving his doctorate in Pharmacodynamics in May of 2006, Dr. Grobe has started postdoctoral training in the laboratory of Curt D.Sigmund, Ph.D. at the University of Iowa (in Iowa City, Iowa). For his postdoctoral work, which has recently been awarded funding through the American Physiological Society’s Postdoctoral Fellowship in Physiological Genomics, Dr. Grobe is examining the pathways and mechanisms of angiotensinergic signalling within cardiovascular control circuits of the brain.